Pharma Industry News
A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.
Big Pharma Has Spent Nearly $150 Billion On M&A (So Far) In 2025
In this week's edition of InnovationRx, we look at the biotech deal frenzy, Recursion's incoming CEO, the infant formula botulism outbreak, and more. To get it in your inbox, subscribe here. Merck announced last week that it would acquire biotech…
US pharma ramps up attack on Australia's 'discriminatory' drug pricing
The US pharmaceutical industry is increasing pressure on Donald Trump to take action against the Pharmaceutical Benefits Scheme, which it says makes Australia one of the most difficult countries in the world to get new medicines approved and…
Purdue Pharma, We Will See You In Hell!
A bankruptcy judge says he will make it official: Purdue Pharma — in business in some form since 1892 and wholly owned by members of the Sackler family since 1952 — shall soon be no more, dissolved, and it and its soon-to-be-former…
Agios Pharma: Study Fail May Affect Mitapivat TDT Approval - Expect More Volatility (AGIO)
Agios Pharmaceuticals, Inc. stock plunged 49% after mixed Phase 3 results for mitapivat in Sickle Cell Disease, raising doubts about future approvals. Mitapivat met the primary hemoglobin endpoint but failed to significantly reduce pain crises or…
ACA Pharma Announces 2026 China NPP Group Procurement Priority List for Orphan and Clinically Urgent Drugs
'China's pediatric and rare-disease hospitals are telling us clearly which therapies they need most, and our job is to turn those requests into practical, compliant access pathways,' said Mike Zhou, CEO, ACA Pharma. 'By combining group NPP access…
Why big pharma is teaming up with AI giants to speed up drug discovery and make work easier for health care workers
AI chip maker Nvidia's fresh partnerships with Eli Lilly and Johnson & Johnson point to a broader trend in the pharmaceutical industry, where tie-ups with AI giants are intended to speed up drug discovery and make work easier for health care…
Piramal Pharma Solutions' Bioconjugates Facility in Grangemouth, UK Receives Updated MHRA GMP Certificates
These certificates cover all activities conducted in the site's Helix building, including its supporting warehouse and laboratory areas. The certificates were granted following the site's submission of an MHRA GMP compliance report and the…
BridgeBio Pharma (NASDAQ:BBIO) CFO Sells $1,125,433.64 in Stock
BridgeBio Pharma, Inc. (NASDAQ:BBIO - Get Free Report) CFO Thomas Trimarchi sold 16,934 shares of the stock in a transaction dated Monday, November 17th. The shares were sold at an average price of $66.46, for a total transaction of $1,125,433.64.
Switzerland releases further CHF50 million Sudan aid
The situation for the civilian population of Sudan and the region has worsened following the capture of the town of El-Fasher by the paramilitary Rapid Support Forces, in the conflict that has pitted them against Sudan's regular armed forces since…
Switzerland misses transalpine freight targets
The access routes are slowing down. The Federal Council is therefore lobbying neighbouring countries for rapid modernisation. The modal shift target of 650,000 lorry journeys set out in the Alpine Initiative adopted in 1994 was also exceeded in…
Swiss army knife maker relieved by US tariff cut
This creates a more manageable framework for exports, Carl Elsener told the AWP news agency on Wednesday. Thanks to this reduction, “the financial sacrifice” for deliveries to the US will be less, he said. At the same time, the…
Wedbush Reiterates Outperform Rating for Ascendis Pharma A/S (NASDAQ:ASND)
Ascendis Pharma A/S (NASDAQ:ASND - Get Free Report)'s stock had its 'outperform' rating reiterated by investment analysts at Wedbush in a report issued on Tuesday, Benzinga reports. They presently have a $220.00 target price on the biotechnology…
India's drug industry saved the world once. Can it do it again?
The phone rang just before midnight. It was early February in 2001 in Mumbai, and Yusuf Hamied, a seasoned chemist at the Indian multinational pharma company Cipla, was at a dinner party. He picked up the phone anyway. A New York Times reporter was…
Ascendis Pharma A/S (NASDAQ:ASND) Shares Gap Up - What's Next?
Ascendis Pharma A/S (NASDAQ:ASND - Get Free Report)'s stock price gapped up before the market opened on Tuesday. The stock had previously closed at $216.56, but opened at $221.89. Ascendis Pharma A/S shares last traded at $215.0240, with a volume…
Ascendis Pharma A/S (NASDAQ:ASND) Now Covered by Analysts at Wolfe Research
Analysts at Wolfe Research initiated coverage on shares of Ascendis Pharma A/S (NASDAQ:ASND - Get Free Report) in a research note issued to investors on Tuesday. The brokerage set a 'peer perform' rating and a $255.00 price target on the…
Receive a Daily briefing on Pharma Industry News
Get Started